Comparison Overview

BioLife Plasma Services

VS

Alembic Pharmaceuticals Limited

BioLife Plasma Services

None, None, Bannockburn , Illinois , US, None
Last Update: 2026-01-25
Between 700 and 749

Every day at BioLife, we feel good knowing that what we do helps improve the lives of patients with rare diseases. While you focus on our donors, we’ll support you. We offer a purpose you can believe in, a team you can count on, opportunities for career growth, and a comprehensive benefits program, all in a fast-paced, friendly environment.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 3,509
Subsidiaries: 0
12-month incidents
0
Known data breaches
1
Attack type number
1

Alembic Pharmaceuticals Limited

Alembic Road, Vadodara, 390003, IN
Last Update: 2026-01-18
Between 750 and 799

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 14,168
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/biolifeplasmaservices.jpeg
BioLife Plasma Services
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/alembic.jpeg
Alembic Pharmaceuticals Limited
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
BioLife Plasma Services
100%
Compliance Rate
0/4 Standards Verified
Alembic Pharmaceuticals Limited
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for BioLife Plasma Services in 2026.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Alembic Pharmaceuticals Limited in 2026.

Incident History — BioLife Plasma Services (X = Date, Y = Severity)

BioLife Plasma Services cyber incidents detection timeline including parent company and subsidiaries

Incident History — Alembic Pharmaceuticals Limited (X = Date, Y = Severity)

Alembic Pharmaceuticals Limited cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/biolifeplasmaservices.jpeg
BioLife Plasma Services
Incidents

Date Detected: 1/2024
Type:Breach
Attack Vector: Credential Stuffing
Blog: Blog
https://images.rankiteo.com/companyimages/alembic.jpeg
Alembic Pharmaceuticals Limited
Incidents

No Incident

FAQ

Alembic Pharmaceuticals Limited company demonstrates a stronger AI Cybersecurity Score compared to BioLife Plasma Services company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

BioLife Plasma Services company has historically faced a number of disclosed cyber incidents, whereas Alembic Pharmaceuticals Limited company has not reported any.

In the current year, Alembic Pharmaceuticals Limited company and BioLife Plasma Services company have not reported any cyber incidents.

Neither Alembic Pharmaceuticals Limited company nor BioLife Plasma Services company has reported experiencing a ransomware attack publicly.

BioLife Plasma Services company has disclosed at least one data breach, while the other Alembic Pharmaceuticals Limited company has not reported such incidents publicly.

Neither Alembic Pharmaceuticals Limited company nor BioLife Plasma Services company has reported experiencing targeted cyberattacks publicly.

Neither BioLife Plasma Services company nor Alembic Pharmaceuticals Limited company has reported experiencing or disclosing vulnerabilities publicly.

Neither BioLife Plasma Services nor Alembic Pharmaceuticals Limited holds any compliance certifications.

Neither company holds any compliance certifications.

Neither BioLife Plasma Services company nor Alembic Pharmaceuticals Limited company has publicly disclosed detailed information about the number of their subsidiaries.

Alembic Pharmaceuticals Limited company employs more people globally than BioLife Plasma Services company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither BioLife Plasma Services nor Alembic Pharmaceuticals Limited holds SOC 2 Type 1 certification.

Neither BioLife Plasma Services nor Alembic Pharmaceuticals Limited holds SOC 2 Type 2 certification.

Neither BioLife Plasma Services nor Alembic Pharmaceuticals Limited holds ISO 27001 certification.

Neither BioLife Plasma Services nor Alembic Pharmaceuticals Limited holds PCI DSS certification.

Neither BioLife Plasma Services nor Alembic Pharmaceuticals Limited holds HIPAA certification.

Neither BioLife Plasma Services nor Alembic Pharmaceuticals Limited holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Typemill is a flat-file, Markdown-based CMS designed for informational documentation websites. A reflected Cross-Site Scripting (XSS) exists in the login error view template `login.twig` of versions 2.19.1 and below. The `username` value can be echoed back without proper contextual encoding when authentication fails. An attacker can execute script in the login page context. This issue has been fixed in version 2.19.2.

Risk Information
cvss3
Base: 5.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N
Description

A DOM-based Cross-Site Scripting (XSS) vulnerability exists in the DomainCheckerApp class within domain/script.js of Sourcecodester Domain Availability Checker v1.0. The vulnerability occurs because the application improperly handles user-supplied data in the createResultElement method by using the unsafe innerHTML property to render domain search results.

Description

A Remote Code Execution (RCE) vulnerability exists in Sourcecodester Modern Image Gallery App v1.0 within the gallery/upload.php component. The application fails to properly validate uploaded file contents. Additionally, the application preserves the user-supplied file extension during the save process. This allows an unauthenticated attacker to upload arbitrary PHP code by spoofing the MIME type as an image, leading to full system compromise.

Description

A UNIX symbolic link following issue in the jailer component in Firecracker version v1.13.1 and earlier and 1.14.0 on Linux may allow a local host user with write access to the pre-created jailer directories to overwrite arbitrary host files via a symlink attack during the initialization copy at jailer startup, if the jailer is executed with root privileges. To mitigate this issue, users should upgrade to version v1.13.2 or 1.14.1 or above.

Risk Information
cvss3
Base: 6.0
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:H
cvss4
Base: 6.0
Severity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:N/SC:N/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

An information disclosure vulnerability exists in the /srvs/membersrv/getCashiers endpoint of the Aptsys gemscms backend platform thru 2025-05-28. This unauthenticated endpoint returns a list of cashier accounts, including names, email addresses, usernames, and passwords hashed using MD5. As MD5 is a broken cryptographic function, the hashes can be easily reversed using public tools, exposing user credentials in plaintext. This allows remote attackers to perform unauthorized logins and potentially gain access to sensitive POS operations or backend functions.